{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T02:11:32Z","timestamp":1778206292388,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.hlc.2026.01.004","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T11:18:32Z","timestamp":1776683912000},"page":"658-667","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preoperative Exposure to Sodium-Glucose Cotransporter-2 Inhibitors and Acute Kidney Injury After Cardiac Surgery: A Retrospective Single-Centre Cohort Study With Overlap Weighting Propensity Score Analysis"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6831-2519","authenticated-orcid":false,"given":"Martin","family":"Ruste","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yann","family":"Le Guennec-Lux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christelle","family":"Berthod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6550-0872","authenticated-orcid":false,"given":"Matteo","family":"Pozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Mewton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Luc","family":"Fellahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Jacquet-Lagr\u00e8ze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlc.2026.01.004_bib1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1001\/jamacardio.2020.4511","article-title":"Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a meta-analysis","volume":"6","author":"McGuire","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hlc.2026.01.004_bib2","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/ehf2.13805","article-title":"Sodium-glucose cotransporter 2 inhibitors in heart failure with reduced or preserved ejection fraction: a meta-analysis","volume":"9","author":"Pandey","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.hlc.2026.01.004_bib3","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2026.01.004_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","author":"The EMPA-KIDNEY Collaborative Group","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2026.01.004_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2021.101315","article-title":"Acute renal injury events in diabetic patients treated with SGLT2 inhibitors: a comprehensive review with a special reference to RAAS blockers","volume":"48","author":"Scheen","year":"2022","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.hlc.2026.01.004_bib6","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.0453","article-title":"Sodium-glucose transport Protein 2 inhibitor use for type 2 diabetes and the incidence of acute kidney injury in Taiwan","volume":"6","author":"Chung","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.hlc.2026.01.004_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s40256-024-00684-y","article-title":"Efficacy of chronic use of sodium-glucose co-transporter 2 inhibitors on the prevention of contrast-induced acute kidney injury in patients with type 2 diabetes mellitus following coronary procedures: a systematic review and meta-analysis","volume":"25","author":"Dimitriadis","year":"2024","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.hlc.2026.01.004_bib8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.34067\/KID.0000000000000375","article-title":"Kidney outcomes with sodium-glucose Cotransporter-2 inhibitor initiation after AKI among veterans with diabetic kidney disease","volume":"5","author":"Murphy","year":"2024","journal-title":"Kidney360"},{"key":"10.1016\/j.hlc.2026.01.004_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40620-022-01422-w","article-title":"Is there any robust evidence showing that SGLT2 inhibitor use predisposes to acute kidney injury?","volume":"36","author":"Copur","year":"2023","journal-title":"J Nephrol"},{"key":"10.1016\/j.hlc.2026.01.004_bib10","unstructured":"Food and Drug Administration. FDA revises labels of SGLT2 inhibitors for diabetes to include warnings about too muchacid in the blood and serious urinary tract infections Available at: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-revises-labels-sglt2-inhibitors-diabetes-include-warnings-about-too-much-acid-blood-and-serious. [Accessed 04.04.25]."},{"key":"10.1016\/j.hlc.2026.01.004_bib11","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1093\/eurheartj\/ehac270","article-title":"2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery","volume":"43","author":"Halvorsen","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2026.01.004_bib12","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1053\/j.jvca.2022.06.008","article-title":"Euglycemic diabetic ketoacidosis associated with sodium-glucose Cotransporter-2 inhibitors after cardiac surgery: a review of current literature","volume":"36","author":"Branco","year":"2022","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.hlc.2026.01.004_bib13","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/ALN.0000000000004734","article-title":"Acute kidney injury after cardiac surgery: prediction, prevention, and management","volume":"139","author":"Cheruku","year":"2023","journal-title":"Anesthesiology"},{"key":"10.1016\/j.hlc.2026.01.004_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae229","article-title":"EValuating the Effect of periopeRaTIve empaGliflOzin on cardiac surgery associated acute kidney injury: rationale and design of the VERTIGO study","volume":"17","author":"Coca","year":"2024","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.hlc.2026.01.004_bib15","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.hlc.2026.01.004_bib16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1684\/ndt.2023.25","article-title":"[How and when to use iSGLT2 (gliflozins) in clinical practice: a consensus for clinical practice proposed by the SFD, the SFC, the CNCF and the SFNDT]","volume":"19","author":"Di\u00e9vart","year":"2023","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.hlc.2026.01.004_bib17","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2026.01.004_bib18","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2026.01.004_bib19","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.hlc.2026.01.004_bib20","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/ejcts\/ezs043","article-title":"EuroSCORE II","volume":"41","author":"Nashef","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.hlc.2026.01.004_bib21","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2026.01.004_bib22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/ALN.0b013e3181979440","article-title":"Development and validation of an acute kidney injury risk index for patients undergoing general surgery: results from a national data set","volume":"110","author":"Kheterpal","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1016\/j.hlc.2026.01.004_bib23","doi-asserted-by":"crossref","first-page":"6150","DOI":"10.1002\/sim.9176","article-title":"Informing power and sample size calculations when using inverse probability of treatment weighting using the propensity score","volume":"40","author":"Austin","year":"2021","journal-title":"Stat Med"},{"key":"10.1016\/j.hlc.2026.01.004_bib24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2288-12-70","article-title":"Evaluation of the propensity score methods for estimating marginal odds ratios in case of small sample size","volume":"12","author":"Pirracchio","year":"2012","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.hlc.2026.01.004_bib25","first-page":"250","article-title":"Addressing extreme propensity scores via the overlap weights","volume":"188","author":"Li","year":"2019","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.hlc.2026.01.004_bib26","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1001\/jama.2020.7819","article-title":"Overlap weighting: A propensity score method that mimics attributes of a randomized clinical trial","volume":"323","author":"Thomas","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.hlc.2026.01.004_bib27","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1214\/19-AOAS1282","article-title":"Propensity score weighting for causal inference with multiple treatments","volume":"13","author":"Li","year":"2019","journal-title":"Ann Appl Stat"},{"key":"10.1016\/j.hlc.2026.01.004_bib28","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/bioinformatics\/btr597","article-title":"MissForest \u2013 non-parametric missing value imputation for mixed-type data","volume":"28","author":"Stekhoven","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.hlc.2026.01.004_bib29","author":"Friedman"},{"key":"10.1016\/j.hlc.2026.01.004_bib30","author":"Zhou"},{"key":"10.1016\/j.hlc.2026.01.004_bib31","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12933-020-01071-y","article-title":"SGLT2i: beyond the glucose-lowering effect","volume":"19","author":"Ni","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.hlc.2026.01.004_bib32","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jama.2024.10510","article-title":"Dapagliflozin for critically ill patients with acute organ dysfunction: the Defender randomized clinical trial","volume":"332","author":"Tavares","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.hlc.2026.01.004_bib33","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/jamasurg.2025.0940","article-title":"Postoperative outcomes among sodium-glucose cotransporter 2 inhibitor users","volume":"160","author":"Tallarico","year":"2025","journal-title":"JAMA Surg"},{"key":"10.1016\/j.hlc.2026.01.004_bib34","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.nefro.2021.05.012","article-title":"Acute kidney injury with sodium-glucose co-transporter-2 inhibitors across the cardiovascular and renal outcome trials: foe or friend?","volume":"43","author":"Patoulias","year":"2023","journal-title":"Nefrologia"},{"key":"10.1016\/j.hlc.2026.01.004_bib35","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1002\/ehf2.13955","article-title":"Empagliflozin reduces markers of acute kidney injury in patients with acute decompensated heart failure","volume":"9","author":"Thiele","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.hlc.2026.01.004_bib36","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s00134-016-4670-3","article-title":"Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial","volume":"43","author":"Meersch","year":"2017","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.hlc.2026.01.004_bib37","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2403769","article-title":"A randomized trial of intravenous amino acids for kidney protection","volume":"391","author":"Landoni","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2026.01.004_bib38","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1053\/j.jvca.2023.01.041","article-title":"Postcardiac surgery euglycemic diabetic ketoacidosis in patients on sodium-glucose cotransporter 2 inhibitors","volume":"37","author":"Auerbach","year":"2023","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.hlc.2026.01.004_bib39","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s00540-024-03335-3","article-title":"Incidence of sodium-glucose cotransporter-2 inhibitor-associated perioperative ketoacidosis in surgical patients: a prospective cohort study","volume":"38","author":"Seki","year":"2024","journal-title":"J Anesth"},{"key":"10.1016\/j.hlc.2026.01.004_bib40","article-title":"Detection of euglycemic diabetic ketoacidosis during thoracic surgery 75 hours after Empagliflozin discontinuation","volume":"14","author":"Nishida","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.hlc.2026.01.004_bib41","doi-asserted-by":"crossref","first-page":"856","DOI":"10.5435\/JAAOS-D-24-00299","article-title":"Patients with diabetes on sodium-glucose Cotransporter-2 inhibitors undergoing total knee arthroplasty are at increased odds for a number of postoperative adverse events but reduced risk of transfusion","volume":"33","author":"Kim","year":"2024","journal-title":"J Am Acad Orthop Surg"},{"key":"10.1016\/j.hlc.2026.01.004_bib42","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/ALN.0000000000004746","article-title":"Meaning and management of perioperative oliguria","volume":"140","author":"Tallarico","year":"2024","journal-title":"Anesthesiology"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950626000338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950626000338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T01:45:32Z","timestamp":1778204732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950626000338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1443950626000338"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2026.01.004","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preoperative Exposure to Sodium-Glucose Cotransporter-2 Inhibitors and Acute Kidney Injury After Cardiac Surgery: A Retrospective Single-Centre Cohort Study With Overlap Weighting Propensity Score Analysis","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2026.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ).","name":"copyright","label":"Copyright"}]}}